Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-19,600
Closed -$3.22M 152
2017
Q1
$3.22M Buy
+19,600
New +$3.26M 0.61% 35
2015
Q4
Sell
-3,500
Closed -$484K 151
2015
Q3
$484K Sell
3,500
-2,200
-39% -$347K 0.16% 63
2015
Q2
$875K Buy
5,700
+2,800
+97% +$449K 0.33% 52
2015
Q1
$464K Buy
+2,900
New +$457K 0.25% 70
2014
Q4
Sell
-5,700
Closed -$801K 241
2014
Q3
$801K Buy
+5,700
New +$744K 0.19% 47
2014
Q1
Sell
-5,300
Closed -$605K 283
2013
Q4
$605K Sell
5,300
-6,900
-57% -$785K 0.19% 50
2013
Q3
$1.36M Buy
+12,200
New +$1.32M 0.83% 26

Other funds holding AMGN

QCM Cayman's AMGN Position: Q1 2021 in Review

QCM Cayman sold out of Amgen (AMGN) in Q1 2021, closing a stake of 1,178 shares — an estimated $271K sold.

QCM Cayman first reported a position in AMGN in Q2 2014 and held it in 8 quarters. The position peaked at $693K in Q4 2015. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • QCM Cayman reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • QCM Cayman sold 1,178 Amgen shares in Q1 2021, an estimated $271K.
  • QCM Cayman first reported a position in Amgen in Q2 2014 and held it in 8 quarters.
  • QCM Cayman's Amgen position peaked at $693K in Q4 2015.
  • 2,219 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on QCM Cayman's 13F filing for Q1 2021, filed 17 May 2021.